11 – 16 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2009
-
Mark
Bio-Distribution of Recombinant Factor VIIa: A Possible Explanation for the Hemostatic Effect of rFVIIa in Prophylaxis
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?
(
- Contribution to journal › Article
- 2007
-
Mark
Recombinant factor VIIa: its background, development and clinical use.
(
- Contribution to journal › Article
- 2004
-
Mark
Recombinant FVIIa.
(
- Contribution to journal › Article
- 1996
-
Mark
Does glycosylation influence the experimental antithrombotic effect of a two-domain tissue factor pathway inhibitor?
(
- Contribution to journal › Article
- 1994
-
Mark
Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin(TM)). An experimental investigation in healthy volunteers
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »